Our Efforts to Develop a COVID-19 Vaccine
GET TO KNOW DR. ANNALIESA ANDERSON, HEAD OF BACTERIAL VACCINES
PROFESSOR JOE SCHMITT TALKS TICK-BOURNE ENCEPHALITIS
HOW ARE VACCINES DEVELOPED?
WHAT YOU NEED TO KNOW ABOUT COVID-19
As announced today by the Austrian Breast & Colorectal Cancer Study Group and the Alliance Foundation Trials, LLC, Pfizer Inc. (NYSE: PFE) reports that following a preplanned efficacy and futility analysis, the independent Data Monitoring Committee (DMC) of the collaborative Phase 3 early breast cancer PAL bociclib Co L laborative A djuvant S tudy (PALLAS) determined that the trial is unlikely to show a statistically significant improvement in the primary endpoint of invasive disease-free…